Abstract
<i>Objective:</i> Lymphoma lesion segmentation and prognosis prediction from baseline FDG-PET images are valuable for tailoring and adapting a treatment plan for patients with Diffuse Large B-cell Lymphoma (DLBCL). However, the tasks are challenging due to the fact that DLBCL is a highly heterogeneous group of neoplasms and that the lymphoma cells are large and arranged in a diffuse pattern. <i>Methods:</i> We propose a novel multi-task 3D convolutional neural network model for simultaneous lymphoma lesion segmentation and prognosis prediction from baseline FDG-PET images. In our model, the learned image features of one task are shared and thereby mutually reinforce the learning of the other task. Since the dataset is limited, to reduce overfitting and to facilitate network convergence, we further introduce deep supervision into both the segmentation task and the prognosis prediction task. <i>Results:</i> Evaluated on a dataset of 269 patients, our method achieved an average Dice similarity coefficient of 0.868 for lesion segmentation, an average AUC (area under the curve) of 0.823 and an average accuracy of 0.821 for prognosis prediction. Its predictions can differentiate patients with different PFS (progression-free survival) and OS (overall survival) (<i>p</i> ˂ 0.0001). <i>Conclusion:</i> Our method achieves joint lymphoma lesion segmentation and prognosis prediction from baseline FDG-PET scans. <i>Significance:</i> Our model may be used to asset the physician as a second opinion while making the final decision.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.